Results 11 to 20 of about 1,015,161 (283)

Beta-lactamases in Enterobacteriaceae infections in children [PDF]

open access: yesJournal of Infection, 2016
Multi-drug resistance in Gram negative bacteria, particularly in Enterobacteriaceae, is a major clinical and public health challenge. The main mechanism of resistance in Enterobacteriaceae is linked to the production of beta-lactamase hydrolysing enzymes such as extended spectrum beta-lactamases (ESBL), AmpC beta-lactamases and carbapenemases ...
Moxon, Christopher Alan   +1 more
openaire   +4 more sources

Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections. [PDF]

open access: yesOpen Forum Infect Dis, 2015
Abstract This article provides a comprehensive review of currently available treatment options for infections due to carbapenem-resistant Enterobacteriaceae (CRE). Antimicrobial resistance in Gram-negative bacteria is an emerging and serious global public health threat.
Morrill HJ   +3 more
europepmc   +7 more sources

Kalkulierte parenterale Initialtherapie bakterieller Infektionen: Infektionen durch multiresistente gramnegative Stäbchen – ESBL-Bildner, Carbapenemase-bildende Enterobacteriaceae, Carbapenem-resistente Acinetobacter baumannii

open access: yesGMS Infectious Diseases, 2020
This is the sixteenth chapter of the guideline “Calculated initial parenteral treatment of bacterial infections in adults – update 2018” in the 2 updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) has been
Grabein, Béatrice   +3 more
doaj   +2 more sources

Clinical and Mortality Risk Factors in Bloodstream Infections with Carbapenem-Resistant Enterobacteriaceae [PDF]

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 2017
Objective. To investigate the risk factors underlying the occurrence and mortality of bloodstream infections (BSIs) with carbapenem-resistant Enterobacteriaceae (CRE). Methods.
Xiaopeng Li, Huan Ye
doaj   +2 more sources

Optimizing therapy in carbapenem-resistant Enterobacteriaceae infections

open access: yesCurrent Opinion in Infectious Diseases, 2018
Purpose of review In the absence of randomized clinical trial data, questions remain regarding the optimal treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections. CRE have historically been susceptible to polymyxins, tigecycline or
Tumbarello M.   +2 more
openaire   +3 more sources

Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Children. [PDF]

open access: yesJ Pediatric Infect Dis Soc, 2020
AbstractInfections due to carbapenem-resistant Enterobacteriaceae (CRE) are increasingly prevalent in children and are associated with poor clinical outcomes. Optimal treatment strategies for CRE infections continue to evolve. A lack of pediatric-specific comparative effectiveness data, uncertain pediatric dosing regimens for several agents, and a ...
Chiotos K, Hayes M, Gerber JS, Tamma PD.
europepmc   +4 more sources

Enterobacteriaceae populations during experimental Salmonella infection in pigs

open access: yesVeterinary Microbiology, 2010
Salmonella infection might affect other intestinal Enterobacteriaceae populations and possible correlations between single Enterobacteriaceae populations would help to predict subclinical Salmonella infections in pigs. In one experimental setup, weaned piglets (n=40) were infected with Salmonella and sacrificed at 3h, 24h, 72 h or 28 days post ...
Sebastian, Guenther   +7 more
openaire   +3 more sources

Carbapenem-Resistant Enterobacteriaceae Infections in Children. [PDF]

open access: yesCurr Infect Dis Rep, 2016
Carbapenem-resistant Enterobacteriaceae (CRE) are an emerging global public health threat. Infections due to CRE are associated with significant morbidity and mortality. Few therapeutic options are available for treatment of these infections, and optimal antibiotic treatment regimens are unclear.
Chiotos K, Han JH, Tamma PD.
europepmc   +4 more sources

Management of carbapenem-resistant Enterobacteriaceae infections [PDF]

open access: yesClinical Microbiology and Infection, 2019
Carbapenem resistance is defined as in vitro non-susceptibility to any carbapenem and/or documented production of a carbapenemase. This feature has rapidly spread worldwide among clinical isolates of Enterobacteriaceae, mostly Klebsiella spp., and is associated with diverse molecular mechanisms. Carbapenem resistance is often associated with resistance
Durante-Mangoni, Emanuele   +2 more
openaire   +3 more sources

INCIDENCE OF ENTEROBACTERIACEAE IN NOSOCOMIAL INFECTIONS

open access: yesANNALS OF THE UNIVERSITY OF CRAIOVA, Biology, Horticulture, Food products processing technology, Environmental engineering, 2023
This work was carried out in the field of General Microbiology, combining in its contents elements of different biological, medical and technological disciplines.The special part of this paper included a study at the Tg-Jiu County Emergency Hospital, where we made a statistic during a calendar year on the number of hospitalized patients, detected with ...
Eleonora Daniela Ciupeanu Călugăru   +1 more
openaire   +1 more source

Home - About - Disclaimer - Privacy